Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapy

1. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106.10.1016/S0140-6736(05)67887-7Search in Google Scholar

2. van Tienhoven G., Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet F, et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999; 35: 32-8.10.1016/S0959-8049(98)00301-3Search in Google Scholar

3. Bedwinek JM, Fineberg B, Lee J, Ocwieza M. Analysis of failures following local treatment of isolated local-regional recurrence of breast cancer. Int JRadiat Oncol Biol Phys 1981; 7: 581-85.10.1016/0360-3016(81)90369-2Search in Google Scholar

4. Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437-47.10.1046/j.1365-201X.2003.01093.xSearch in Google Scholar

5. Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anti-Cancer Drugs 1998; 9: 319-25.10.1097/00001813-199804000-00005Search in Google Scholar

6. Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. CancerTreat Rev 2003; 29: 371-87.10.1016/S0305-7372(03)00073-2Search in Google Scholar

7. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy, An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Supplements 2006; 4: 3-13.10.1016/j.ejcsup.2006.08.002Search in Google Scholar

8. Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients. Ann Surg Oncol 2009; 16: 191-9.10.1245/s10434-008-0204-8Search in Google Scholar

9. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J, Jr., Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993; 72: 3694-700.10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2Search in Google Scholar

10. Curatolo P, Quaglino P, Marenco F, Mancini M, Nardo T, Mortera C, et al. Electrochemotherapy in the Treatment of Kaposi Sarcoma Cutaneous Lesions: A Two-Center Prospective Phase II Trial. Ann Surg Oncol 2011. 19: 192-80.10.1245/s10434-011-1860-7Search in Google Scholar

11. Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77: 964-71.10.1002/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0Search in Google Scholar

12. Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, Kessel G, Humphreys AC, et al. Management of cutaneous metastases using electrochemotherapy. Acta Oncol 2011; 50: 621-9.10.3109/0284186X.2011.573626Search in Google Scholar

13. Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008; 15: 2215-22.10.1245/s10434-008-9976-0Search in Google Scholar

14. Matthiessen LW, Johannesen HH, Hendel HW, Moss T, Kamby C, Gehl J. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol 2012; 51: 713-21.10.3109/0284186X.2012.685524Search in Google Scholar

15. Sersa G, Cufer T, Paulin SM, Cemazar M, Snoj M. Electrochemotherapy of chest wall breast cancer recurrence. Cancer Treat Rev 2012; 38: 379-86.10.1016/j.ctrv.2011.07.006Search in Google Scholar

16. Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, Jensen KS, et al. Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res 2011; 71: 3753-62.10.1158/0008-5472.CAN-11-0451Search in Google Scholar

17. Linnert M, Gehl J. Bleomycin treatment of brain tumors: an evaluation. Anticancer Drugs 2009; 20: 157-64.10.1097/CAD.0b013e328325465eSearch in Google Scholar

18. Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A et al. Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat 2011; 10: 475-85.10.7785/tcrt.2012.500224Search in Google Scholar

19. Jansson T, Westlin JE, Ahlstrom H, Lilja A, Langstrom B, Bergh J. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? J ClinOncol 1995; 13: 1470-77.Search in Google Scholar

20. Bassa P, Kim EE, Inoue T, Wong FC, Korkmaz M, Yang DJ, et al. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer. J Nucl Med 1996; 37: 931-8.Search in Google Scholar

21. Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994; 35: 1308-12.Search in Google Scholar

22. Lodge MA, Lucas JD, Marsden PK, Cronin BF, O’Doherty MJ, Smith MA. A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med 1999; 26: 22-30.10.1007/s002590050355Search in Google Scholar

23. Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002; 43: 871-5.Search in Google Scholar

24. Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li, P et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001; 42: 1412-7.Search in Google Scholar

25. Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or noninvasive electrodes. EJC Supplements 2006; 4: 14-25.10.1016/j.ejcsup.2006.08.003Search in Google Scholar

26. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. JNatl Cancer Inst 2000; 92: 205-16.10.1093/jnci/92.3.205Search in Google Scholar

27. Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 1999; 35: 1773-82.10.1016/S0959-8049(99)00229-4Search in Google Scholar

28. Boerner AR, Weckesser M, Herzog H, Schmitz T, Audretsch W, Nitz U, et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med 1999; 26: 226-30.10.1007/s002590050381Search in Google Scholar

29. Caprio MG, Cangiano A, Imbriaco M, Soscia F, Di Martina G, Farina A et al. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions. Radiol Med 2010; 115: 215-24.10.1007/s11547-009-0491-6Search in Google Scholar

30. Weinberg IN. Applications for positron emission mammography. Phys Med 2006; 21 (Suppl 1): 132-37.10.1016/S1120-1797(06)80045-1Search in Google Scholar

31. Linnert M, Iversen HK, Gehl J. Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy. RadiolOncol 2012; 46: 271-78.10.2478/v10019-012-0042-y357289423412694Search in Google Scholar

32. Miklavcic D, Sersa G, Brecelj E, Gehl J, Soden D, Bianchi G, et al. Electrochemotherapy: technological advancements for efficient electroporation- based treatment of internal tumors. Med Biol Eng Comput 2012; 50: 1213-25.10.1007/s11517-012-0991-8351469923179413Search in Google Scholar

33. Mozzillo N, Caraco C, Mori S, Di Monta G, Botti G, Ascierto PA, et al. Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma. J Transl Med 2012; 10: 131.10.1186/1479-5876-10-131340398122800396Search in Google Scholar

34. Neal RE, Rossmeisl JH, Jr., Garcia PA, Lanz OI, Henao-Guerrero N, Davalos RV. Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol 2011; 29: e372-7. 10.1200/JCO.2010.33.090221321291Search in Google Scholar